Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Agile Therapeutics

Request full access

Agile Therapeutics (C)2011

Princeton, United StatesFounded 1997Biotech & Life Sciences

About Agile Therapeutics

Agile Therapeutics is a healthcare company focused on developing and commercializing innovative contraceptive products for women. The company operates in the pharmaceutical and biotechnology market, specifically targeting women's health. Agile Therapeutics is committed to providing women with more choices in their healthcare, which is reflected in their product pipeline and their proprietary Skinfusion Technology. This technology is used in all of their current products and product candidates, ensuring effective and reliable delivery of medication through the skin.

The company's flagship product, Twirla, is a contraceptive patch that offers an alternative to traditional birth control methods. Twirla is designed to be easy to use and provides a consistent dose of hormones to prevent pregnancy. Agile Therapeutics serves women who are looking for convenient and effective contraceptive options.

Agile Therapeutics operates on a business model that involves the research, development, and commercialization of pharmaceutical products. They generate revenue primarily through the sale of their approved products, like Twirla. Additionally, they invest in ongoing research and development to expand their product offerings and improve existing ones. The company also collaborates with third parties under confidentiality agreements to enhance their operations and services.

In summary, Agile Therapeutics is dedicated to advancing women's health by offering innovative contraceptive solutions. Their focus on research and development, combined with their proprietary technology, positions them as a key player in the women's healthcare market.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2014
Outcome tier
Colt$25–100M revenue

Agile Therapeutics in the Princeton ecosystem

Live from Dealroom

The Agile Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • The Hillman Companies

Series A2 investors entered at this stage

  • Care Capital
  • Investor Growth Capital

Series B and later6 investors entered at this stage

Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States88.9%
🇧🇪 Belgium11.1%
2 countries shown
Web traffic by country
1.6K monthly visits
across markets
🇺🇸 United States100%
Top 1 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Agile Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Agile Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.